Content related to CHLA Neuroimmunology Expert Jonathan Santoro Featured in Washington Post Article About Breakthrough Discovery in Down Syndrome Regression Disorder

Jonathan Santoro, MD, is pioneering a novel treatment—and the first clinical trial— for Down syndrome regression disorder, a devastating condition in young people with Down syndrome.

When athlete Darci suddenly became catatonic, her mom learned of a new Down syndrome regression disorder treatment at CHLA that is bringing her back to herself.

A neuroimmunologist at Children’s Hospital Los Angeles led an effort to create an ICD-10 code for MOGAD—helping to speed access to critical medications.

A Children’s Hospital Los Angeles expert shares the latest on tuberous sclerosis complex care and research.

First, he wiggled his fingers. Then he wiggled his toes. Now, he moves his head side to side, and he furrows his eyebrows when he doesn’t agree with you. For 3-year-old Ali Al-Mutawa—and for his

A range of specialists at CHLA collaborated to care for a young patient with the new disorder effecting children who have had COVID-19

The multidisciplinary clinic provides highly specialized comprehensive care and allows families to see several specialists on the same day.

On June 18, more than 450 researchers, physicians, trainees and staff gathered to share novel findings, discuss current challenges and forge new scientific collaborations at Science Day 2024—The Saban

Gene therapy holds tremendous potential for children, but many promising therapies are shelved. Here’s what a new model could look like.